000 | 01003 a2200301 4500 | ||
---|---|---|---|
005 | 20250513000110.0 | ||
264 | 0 | _c19810413 | |
008 | 198104s 0 0 eng d | ||
022 | _a0361-5960 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarrell, R P | |
245 | 0 | 0 |
_aPhase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma. _h[electronic resource] |
260 |
_bCancer treatment reports _c |
||
300 |
_a1157-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAminoacridines _xadverse effects |
650 | 0 | 4 | _aAmsacrine |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma _xdrug therapy |
650 | 0 | 4 | _aMiddle Aged |
700 | 1 | _aStraus, D J | |
700 | 1 | _aYoung, C W | |
773 | 0 |
_tCancer treatment reports _gvol. 64 _gno. 10-11 _gp. 1157-8 |
|
999 |
_c6893680 _d6893680 |